[Long-term survival of a patient with giant liver metastatic breast cancer treated with trastuzumab].
Naoya Okada, O Matsunami, Yoshiyasu Ambo(Hokkaido University of Science), Akihiro Kishida, Yoshihide Nanno, Tõru Nakamura, Yoshiaki Narita, Fumitaka Nakamura, Mayu Shimaguchi, Rei Inoue, Hiroaki Kato(Teine Keijinkai Hospital), Nobuichi Kashimura, Minoru Takada(Kindai University Hospital), Kiyotaka Imamura(Teine Keijinkai Hospital), On Suzuki(Hokkaido University)
PubMed
September 1, 2012
Cited by 2
Related Papers
Activation of ERBB2 Signaling Causes Resistance to the EGFR-Directed Therapeutic Antibody Cetuximab
|Science Translational Medicine|2011|670
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Body Cancer
|Annals of Surgery|2007|315